Skip to main content
Tech.euFundingExplorerBeta

DNA Script

DNA Script is a programmable biology company that develops enzymatic DNA synthesis technology and the SYNTAX DNA printer.

DNA Script has raised €264M across 5 funding rounds from 24 investors, most recently a Series C round in Jan 2022. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€264M
€263,881,085
Funding rounds
5
Investors
24
distinct backers
Active since
2017-07
latest 2022-01

Funding by year

EUR raised per year
DNA Script — funding by year — interactive chart.
Data table
DNA Script — funding by year
2017€11M
2019€34M
2020€46M
2021€142M
2022€31M

Signals

High confidence
Raise-next likelihood8
base rate 50% for Series C
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood17
base rate 11% (2+ rounds)
  • ▲ €100M+ raised
  • ▲ 5 rounds raised
  • ▲ 9y since founding (typical exit age)
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.